Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costs

Respiratory Medicine

Volumn 105, Issue 3, 2011, Pages 435-441

  Toy, Edmond L ^a   Beaulieu, Nicolas U ^b   McHale, Joshua M ^b   Welland, Timothy R ^a   Plauschinat, Craig A ^c   Swensen, Andrine ^c   Duh, Mei Sheng ^b  

^a Analysis Group Inc   (United States)

^b ANALYSIS GROUP   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adherence; Compliance; COPD; Cost; Dosing frequency

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL; SALMETEROL; TIOTROPIUM BROMIDE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DATA BASE; DEMOGRAPHY; DOSIMETRY; DRUG COST; DRUG USE; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION;

AGED; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES NEEDS AND DEMAND; HOSPITALIZATION; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES;

EID: 79251477170     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.09.006     Document Type: Article

References (22)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2008 update Available at http://www.goldcopd.com [accessed 31.07.09.]
2. D.M. Mannino, and S. Braman The epidemiology and economics of chronic obstructive pulmonary disease Proc Am Thorac Soc 4 2007 502 506
3. U.S. Department of Health and Human Services. National Institutes of Health. National Heart Lung and Blood Institute. Morbidity and mortality: 2007 chart book on cardiovascular, lung and blood diseases.
4. S.D. Ramsey Suboptimal medical therapy in COPD: exploring the causes and consequences Chest 117 Suppl. 2 2000 33S 37S
5. C.S. Rand Patient adherence with COPD therapy Eur Respir Rev 14 96 2005 97 101
6. N.S. Breekveldt-Postma, J. Koerselman, J.A. Erkens, J.J. Lammers, and R.M.C. Herings Enhanced persistence with tiotropium compared with other respiratory drugs in COPD Respir Med 101 2007 1398 1405
7. J.A. Cramer Partial medication compliance: the enigma in poor medical outcomes Am J Manag Care 1 1995 45 52
8. J.A. Cramer, and B. Spilker Patient compliance in medical practice and clinical trials 1991 Raven Press New York
9. G.M. Cochrane, R. Horne, and P. Chanez Compliance in asthma Respir Med 93 11 1999 763 769
10. J. George, D.C. Kong, R. Thoman, and K. Stewart Factors associated with medication nonadherence in patients with COPD Chest 128 5 2005 3198 3204
11. D.L. Sackett, and R.B. Haynes Compliance with therapeutic regimens 1976 John Hopkins University Press Baltimore
12. T.L. Venebles, M.B. Addlestone, and A.J. Smithers A comparison of the efficacy and patient acceptability of once daily budesonide via turbuhaler and twice daily fluticasone propionate via a disc-inhaler at an equal dose of 400mcg in adult asthmatics Br J Clin Res 7 1996 15 32
13. M.N. Stagnitti, K. Beauregard, and A. Solis Design, methods, and field results of the Medical Expenditure Panel Survey Medical Provider Component (MEPS MPC) - 2006 calendar year data, methodology report no. 23 November 2008 Agency for Healthcare Research and Quality Rockville, MD Available at http://www.meps.ahrq.gov/mepsweb/data-files/publications/mr23/mr23.pdf [accessed 20.08.09.]
14. Bureau of Labor Statistics Measuring Price change for medical care in CPI Accessed online at http://www.bls.gov/cpi/cpifact4.htm [accessed 12.6.09.]
15. Prescribing Information Labels were obtained from the U.S. Food and Drug Administration website Available at http://www.accessdata.fda.gov/scripts/cder/ ob/default.cfm [accessed September 2008]
16. J.S. Benner, R.J. Glynn, H. Mogun, P.J. Neumann, M.C. Weinstein, and J. Avorn Long-term persistence in use of statin therapy in elderly patients JAMA 288 2002 455 461
17. P.S. Romano, L.L. Roos, and J.G. Jollis Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives J Clin Epidemiol 46 1993 1075 1109 discussion 1081-1090
18. E.Q. Wu, H.G. Birnbaum, M. Cifaldi, Y. Kang, D. Mallet, and G. Colice Development of a COPD severity score Curr Med Res Opin 22 9 2006 1679 1687
19. M. Iskedjian, T.R. Einarson, L.D. MacKeigan, N. Shear, A. Addis, and N. Mittman Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis Clin Ther 24 2 2002 302 316
20. A.J. Claxton, J. Cramer, and C. Pierce A systematic review of the associations between dose regimens and medication compliance Clin Ther 23 8 2001 1296 1310
21. B.G. Bender, A. Pedan, and L.T. Varasteh Adherence and persistence with fluticasone propionate/salmeterol combination therapy J Allergy Clin Immunol 118 4 2006 899 904
22. N. Muszbek, D. Brixner, A. Benedict, A. Keskinaslan, and Z.M. Khan The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review Int J Clin Pract 62 2 2008 338 351